These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6706511)

  • 1. Complement inhibitors in normal cornea and aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):483-6. PubMed ID: 6706511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for glomerular modulation of complement activation.
    Moseley HL; Whaley K
    J Clin Lab Immunol; 1979 Apr; 2(1):9-13. PubMed ID: 95813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1 inactivator and C3b inactivator in peripheral lymph of normal men.
    Olszewski WL; Lukomska B; Engeset A
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):79-86. PubMed ID: 7149928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
    Wyatt RJ; Bridges RB; Halatek DG
    J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement levels in normal and inflamed aqueous humor.
    Mondino BJ; Rao H
    Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):380-4. PubMed ID: 6550582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation.
    Goslings WR; Prodeus AP; Streilein JW; Carroll MC; Jager MJ; Taylor AW
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):989-95. PubMed ID: 9579478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Homeostasis of the complement system--complement inhibitors].
    Nagaki K
    Nihon Rinsho; 1979 May; 37(5):969-76. PubMed ID: 381728
    [No Abstract]   [Full Text] [Related]  

  • 8. C3b inactivator in normal mice and mice infected with Plasmodium berghei berghei.
    Okerengwo AA
    Afr J Med Med Sci; 1988 Sep; 17(3):171-4. PubMed ID: 2845758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of complement activation in membranous and membranoproliferative glomerulonephritis.
    Moseley HL; Whaley K
    Kidney Int; 1980 Apr; 17(4):535-44. PubMed ID: 6446614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement levels of C4, C3C, factor B, and C1 inactivator in peripheral and retroplacental blood of parturient women with EPH gestosis.
    Zdanowicz A; Jabłońska E; Pietruska Z; Bielecki M
    Ann Med Univ Bialyst Pol; 1993; 38(1):60-7. PubMed ID: 7922487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of C3c, C4 and C1-esterase inhibitor (C1-INH) during unstable angina].
    Danese C; Marcianò F; Ciarla MV; Colotto M; Angrisani L; Ferranti E; Borgia MC
    Minerva Cardioangiol; 2002 Dec; 50(6):667-72. PubMed ID: 12473987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated complement in inflamed aqueous humor.
    Mondino BJ; Glovsky MM; Ghekiere L
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):871-3. PubMed ID: 6610667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
    Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
    J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute-phase reactant proteins and complement components and inhibitors in patients with ovarian cancer.
    Lukomska B; Olszewski WL; Engeset A; Kolstad P
    Gynecol Oncol; 1981 Jun; 11(3):288-98. PubMed ID: 6166517
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
    Wuillemin WA; te Velthuis H; Lubbers YT; de Ruig CP; Eldering E; Hack CE
    J Immunol; 1997 Aug; 159(4):1953-60. PubMed ID: 9257861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
    Potter BJ; Brown DJ; Watson A; Jewell DP
    Gut; 1980 Dec; 21(12):1030-4. PubMed ID: 6450718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of inhibitor of the first component of complement (C1 INH) in patients with hereditary angioedema].
    Rivero S; Gajardo M; Guzmán L
    Rev Med Chil; 1982 May; 110(5):444-8. PubMed ID: 6819622
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.
    Weiss V; Engel J
    Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):295-301. PubMed ID: 6602754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.